foxo4-dri peter de keizer – Longevity Med Summit The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Peter DE KEIZER Professor (Associate) PhD University Medical Center Utrecht, Utrecht UMC Utrecht Molecular Medicine Research profile FOXO4 DRI Peptide 10 mg FOXO4 DRI: pricey, but was worth trying out in my opinion. How will I know the long term benefits? I guess I won't. See you guys when I'm 90 to report back.
Pay in 4 interest-free payments of $6.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


